Search Results

240 results for AINV

VRTS Stock Earnings: Virtus Inv Misses EPS, Beats Revenue for Q2 2024

VRTS stock results show that Virtus Inv missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

SEIC Stock Earnings: SEI Inv Beats EPS, Misses Revenue for Q2 2024

SEIC stock results show that SEI Inv beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

SEIC Stock Earnings: SEI Inv Beats EPS, Beats Revenue for Q1 2024

SEIC stock results show that SEI Inv beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

VRTS Stock Earnings: Virtus Inv Meets EPS, Beats Revenue for Q1 2024

VRTS stock results show that Virtus Inv met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

SLRC Stock Earnings: SLR Inv Beats EPS, Misses Revenue for Q1 2024

SLRC stock results show that SLR Inv beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

GAIN Stock Earnings: Gladstone Inv Misses EPS, Beats Revenue for Q4 2024

GAIN stock results show that Gladstone Inv missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2024.

GAIN Stock Earnings: Gladstone Inv Misses EPS, Misses Revenue for Q1 2025

GAIN stock results show that Gladstone Inv missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2025.

ANVS Stock: The Huge News Sending Annovis Bio Rocketing 200% Today

A dual Alzheimer’s-Parkinson’s clinical trial is showing highly optimistic results for Annovis, and ANVS stock is up huge because of it.

VINP Stock Earnings: Vinci Partners Inv Misses EPS, Beats Revenue for Q1 2024

VINP stock results show that Vinci Partners Inv missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

VINP Stock Earnings: Vinci Partners Inv Beats EPS, Beats Revenue for Q2 2024

VINP stock results show that Vinci Partners Inv beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

BKCC Stock Earnings: BlackRock Cap Inv Meets EPS, Misses Revenue for Q4 2023

BKCC stock results show that BlackRock Cap Inv met analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

Hottest Services Stocks Now – QUMU CYH TTD FLY

The following stocks were moving the Services sector today.

Hottest Services Stocks Now – WK AMBR XTLY EXA

The Services sector saw plenty of trading activity today, including the following leaders and losers.

Hottest Services Stocks Now – GRVY TAL OUTR MEET

The following stocks were moving the Services sector today.

Hottest Services Stocks Now – AINC QUMU BCOV GUID

The following stocks were moving the Services sector today.

Hottest Services Stocks Now – EXEL EGL GSB AINC

The following stocks were moving the Services sector today.

Biggest Movers in Services Stocks Now – GUID SALE NEWR BNFT

The Services sector saw plenty of trading activity today, including the following leaders and losers.

Hottest Services Stocks Now – CDRB JP AAN TMH

The following stocks were moving the Services sector today.

Why Is iLearningEngines (AILE) Stock Down 33% Today?

IlearningEngines stock is falling hard on Monday after the company launched an offer for AILE shares this morning.

FINV Stock Earnings: FinVolution Gr Reported Results for Q2 2024

FinVolution Gr just reported results for the second quarter of 2024.

FINV Stock Earnings: FinVolution Gr Reported Results for Q1 2024

FinVolution Gr just reported results for the first quarter of 2024.

The 7 Most Undervalued Stocks Under $10 to Buy Now: August 2023

While consumer prices may be hot, these stocks undervalued stocks to buy under $10 proves you can still catch a bargain.

FINV Stock Earnings: FinVolution Gr Misses Revenue for Q4 2023

FINV stock results show that FinVolution Gr missed on revenue for the fourth quarter of 2023.

Why Is Applied Therapeutics (APLT) Stock Down 30% Today?

Applied Therapeutics stock is tumbling on Friday as investors react to lackluster results from a Phase 3 clinical trial of AT-001.

5 – 10 of 240 results